The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Substrate Specificity of Heparanases from Human Hepatoma and Platelets
Open accessAbstract
Heparan sulfate proteoglycans, attached to cell surfaces or in the extracellular matrix, interact with a multitude of proteins via their heparan sulfate side chains. Degradation of these chains by limited (endoglycosidic) heparanase cleavage is believed to affect a variety of biological processes. Although the occurrence of heparanase activity in mammalian tissues has been recognized for many years, the molecular characteristics and substrate recognition properties of the enzyme(s) have remained elusive. In the present study, the substrate specificity and cleavage site of heparanase from human hepatoma and platelets were investigated. Both enzyme preparations were found to cleave the single beta-D-glucuronidic linkage of a heparin octasaccharide. A capsular polysaccharide from Escherichia coli K5, with the same (-GlcUAbeta1,4-GlcNAcalpha1,4-)n structure as the unmodified backbone of heparan sulfate, resisted heparanase degradation in its native state as well as after chemical N-deacetylation/N-sulfation or partial enzymatic C-5 epimerization of beta-D-GlcUA to alpha-L-IdceA. By contrast, a chemically O-sulfated (but still N-acetylated) K5 derivative was susceptible to heparanase cleavage. O-Sulfate groups, but not N-sulfate or IdceA residues, thus are essential for substrate recognition by the heparanase(s). In particular, selective O-desulfation of the heparin octasaccharide implicated a 2-O-sulfate group on a hexuronic acid residue located two monosaccharide units from the cleavage site, toward the reducing end.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Formation of anhydrosugars in the chemical depolymerization of heparin
Shively, J. E., & Conrad, H. E. (1976) · Biochemistry · doi:10.1021/bi00663a005 · Cited by 901
Bashkin, P., Doctrow, S., Klagsbrun, M., Svahn, C. M., Folkman, J., & Vlodavsky, I. (1989) · Biochemistry · doi:10.1021/bi00430a047 · Cited by 590
Self-citationFurther characterization of the antithrombin-binding sequence in heparin
Thunberg, L., Bäckström, G., & Lindahl, U. (1982) · Carbohydrate Research · doi:10.1016/s0008-6215(00)81050-2 · Cited by 455
Self-citationHeparan sulfate: a piece of information
Salmivirta, M., Lidholt, K., & Lindahl, U. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.11.8836040 · Cited by 439
Self-citationIntegral membrane heparan sulfate proteoglycans
David, G. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.11.8370471 · Cited by 418
Rosenberg, R. D., Shworak, N. W., Liu, J., Schwartz, J. J., & Zhang, L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119377 · Cited by 385
Nakajima, M., Irimura, T., Ferrante, D. D., Ferrante, N. D., & Nicolson, G. L. (1983) · Science · doi:10.1126/science.6220468 · Cited by 346
More to “heparin” than anticoagulation
Lindahl, U., Lidholt, K., Spillmann, D., & Kjellén, L. (1994) · Thrombosis Research · doi:10.1016/0049-3848(94)90136-8 · Cited by 340
Self-citationNagasawa, K., Inoue, Y., & Kamata, T. (1977) · Carbohydrate Research · doi:10.1016/s0008-6215(00)83402-3 · Cited by 310
Heparanases and tumor metastasis
Nakajima, M., Irimura, T., & Nicolson, G. L. (1988) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240360207 · Cited by 305
Cited by
The Structure of Glycosaminoglycans and their Interactions with Proteins
Gandhi, N. S., & Mancera, R. L. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00741.x · Cited by 1,034
Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., et al. (1999) · Nature Medicine · doi:10.1038/10518 · Cited by 803
Self-citationMolecular properties and involvement of heparanase in cancer metastasis and angiogenesis
Vlodavsky, I., & Friedmann, Y. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13662 · Cited by 618
Self-citationRegulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
Ilan, N., Elkin, M., & Vlodavsky, I. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.06.004 · Cited by 524
Self-citationCloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
Hulett, M. D., Freeman, C., Hamdorf, B. J., Baker, R. T., Harris, M. J., & Parish, C. R. (1999) · Nature Medicine · doi:10.1038/10525 · Cited by 518
Structure and biological interactions of heparin and heparan sulfate
Casu, B., & Lindahl, U. (2001) · Advances in Carbohydrate Chemistry and Biochemistry · doi:10.1016/s0065-2318(01)57017-1 · Cited by 375
Self-citationNovel drug development opportunities for heparin
Lever, R., & Page, C. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd724 · Cited by 328
Heparan Sulfate: Biosynthesis, Structure, and Function
(2016) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2016.02.009 · Cited by 298
A systems approach to prion disease
Hwang, D., Lee, I. Y., Yoo, H., Gehlenborg, N., Cho, J., Petritis, B., Baxter, D., Pitstick, R., Young, R., Spicer, D., et al. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.10 · Cited by 287
GLYCOMICS APPROACH TO STRUCTURE-FUNCTION RELATIONSHIPS OF GLYCOSAMINOGLYCANS
Sasisekharan, R., Raman, R., & Prabhakar, V. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095745 · Cited by 278
Elgundi, Z., Papanicolaou, M., Major, G., Cox, T. R., Melrose, J., Whitelock, J. M., & Farrugia, B. L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01482 · Cited by 176
Capila, I., & Linhardt, R. J. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020201)41:3<390::aid-anie390>3.0.co;2-b
Metadata
- Authors
- Pikas, D. S., Li, J.-P., Vlodavsky, I., & Lindahl, U.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-07
- Volume
- 273
- Issue
- 30
- Pages
- 18770-18777
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1989676517
- Cited by
- 261
- References
- 39
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.